Author： Rini Brian I
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.4, 2006-03, pp. : 453-461
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Mangana Joanna Levesque Mitchell P Karpova Maria B Dummer Reinhard
Expert Opinion on Investigational Drugs, Vol. 21, Iss. 4, 2012-04 ,pp. :
Access to resources
Recommend
Increased hypertension risk with sorafenib
Inpharma, Vol. 1, Iss. 1623, 2008-01 ,pp. :
Sorafenib: Thyroiditis: case report
Reactions Weekly, Vol. 1, Iss. 1325, 2010-01 ,pp. :
Sorafenib: Hyperglycaemia: case report
Reactions Weekly, Vol. 1, Iss. 1429, 2012-01 ,pp. :
Sorafenib: Toxicoderma: case report
Reactions Weekly, Vol. 1, Iss. 1272, 2009-01 ,pp. :